{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:f95bc419-f349-4b0d-896d-2572577699d0","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-17T09:43:31.314654+00:00","published_at":"2026-10-17T04:45:23.017038+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:vq21741eb47mo","event_type":"DIRECTOR_APPOINTED","effective_at":"2026-01-01","detected_at":"2026-10-17T04:45:23.017038+00:00","subject_ids":["alpha:person:stuart-a-arbuckle","alpha:company:f95bc419-f349-4b0d-896d-2572577699d0"],"caused_claim_ids":["alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:15"],"evidence_ids":["alpha:projection-evidence:document:7a71310a5f06fcc54110ecee3706ed18f0dacca342c3541f614d391dd6766dcd"],"summary":"Stuart A. Arbuckle seat on ALNYLAM PHARMACEUTICALS, INC., effective 2026-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:vx3xbck7c5es","event_type":"DIRECTOR_APPOINTED","effective_at":"2023-01-01","detected_at":"2026-10-17T04:45:23.017038+00:00","subject_ids":["alpha:person:peter-n-kellogg","alpha:company:f95bc419-f349-4b0d-896d-2572577699d0"],"caused_claim_ids":["alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:14"],"evidence_ids":["alpha:projection-evidence:document:7a71310a5f06fcc54110ecee3706ed18f0dacca342c3541f614d391dd6766dcd"],"summary":"Peter N. Kellogg seat on ALNYLAM PHARMACEUTICALS, INC., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:qbc4oqerybf4","event_type":"COMMITTEE_CREATED","effective_at":"2023-01-01","detected_at":"2026-10-17T04:45:23.017038+00:00","subject_ids":["alpha:committee:alnylam-pharmaceuticals-inc:audit-chair","alpha:company:f95bc419-f349-4b0d-896d-2572577699d0"],"caused_claim_ids":["alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:14"],"evidence_ids":["alpha:projection-evidence:document:7a71310a5f06fcc54110ecee3706ed18f0dacca342c3541f614d391dd6766dcd"],"summary":"Audit · Chair committee of ALNYLAM PHARMACEUTICALS, INC., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1ecyn3m11m84ps","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2023-01-01","detected_at":"2026-10-17T04:45:23.017038+00:00","subject_ids":["alpha:person:peter-n-kellogg","alpha:committee:alnylam-pharmaceuticals-inc:audit-chair"],"caused_claim_ids":["alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:14"],"evidence_ids":["alpha:projection-evidence:document:7a71310a5f06fcc54110ecee3706ed18f0dacca342c3541f614d391dd6766dcd"],"summary":"Peter N. Kellogg member of Audit · Chair, effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:lg5ioy14uutcs","event_type":"DIRECTOR_APPOINTED","effective_at":"2022-01-01","detected_at":"2026-10-17T04:45:23.017038+00:00","subject_ids":["alpha:person:elliott-sigal","alpha:company:f95bc419-f349-4b0d-896d-2572577699d0"],"caused_claim_ids":["alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:7a71310a5f06fcc54110ecee3706ed18f0dacca342c3541f614d391dd6766dcd"],"summary":"Elliott Sigal seat on ALNYLAM PHARMACEUTICALS, INC., effective 2022-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1os05wk6d3ack","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-17T04:45:23.017038+00:00","subject_ids":["alpha:person:yvonne-l-greenstreet-2","alpha:company:f95bc419-f349-4b0d-896d-2572577699d0"],"caused_claim_ids":["alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:16"],"evidence_ids":["alpha:projection-evidence:document:7a71310a5f06fcc54110ecee3706ed18f0dacca342c3541f614d391dd6766dcd"],"summary":"Yvonne L. Greenstreet seat on ALNYLAM PHARMACEUTICALS, INC., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:lqcz2mrfo2jg","event_type":"DIRECTOR_APPOINTED","effective_at":"2020-01-01","detected_at":"2026-10-17T04:45:23.017038+00:00","subject_ids":["alpha:person:olivier-brandicourt","alpha:company:f95bc419-f349-4b0d-896d-2572577699d0"],"caused_claim_ids":["alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:13"],"evidence_ids":["alpha:projection-evidence:document:7a71310a5f06fcc54110ecee3706ed18f0dacca342c3541f614d391dd6766dcd"],"summary":"Olivier Brandicourt seat on ALNYLAM PHARMACEUTICALS, INC., effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1tjj8t57chlun","event_type":"DIRECTOR_APPOINTED","effective_at":"2019-01-01","detected_at":"2026-10-17T04:45:23.017038+00:00","subject_ids":["alpha:person:margaret-a-hamburg","alpha:company:f95bc419-f349-4b0d-896d-2572577699d0"],"caused_claim_ids":["alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:7a71310a5f06fcc54110ecee3706ed18f0dacca342c3541f614d391dd6766dcd"],"summary":"Marc D. Hamburg seat on ALNYLAM PHARMACEUTICALS, INC., effective 2019-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:njparlauc93d","event_type":"DIRECTOR_APPOINTED","effective_at":"2018-01-01","detected_at":"2026-10-17T04:45:23.017038+00:00","subject_ids":["alpha:person:colleen-f-reitan","alpha:company:f95bc419-f349-4b0d-896d-2572577699d0"],"caused_claim_ids":["alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:7a71310a5f06fcc54110ecee3706ed18f0dacca342c3541f614d391dd6766dcd"],"summary":"Colleen F. Reitan seat on ALNYLAM PHARMACEUTICALS, INC., effective 2018-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:y3rjm2nd1eu","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2018-01-01","detected_at":"2026-10-17T04:45:23.017038+00:00","subject_ids":["alpha:person:colleen-f-reitan","alpha:committee:alnylam-pharmaceuticals-inc:audit"],"caused_claim_ids":["alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:committee_record:26"],"evidence_ids":["alpha:projection-evidence:9ba1004d067de3d8e8ee090fc3af01300f3a277f7267ddfe2b5b1800b9366fa8"],"summary":"Colleen F. Reitan member of Audit, effective 2018-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1vb8fhxxrlfd1","event_type":"DIRECTOR_APPOINTED","effective_at":"2015-01-01","detected_at":"2026-10-17T04:45:23.017038+00:00","subject_ids":["alpha:person:david-e-i-pyott","alpha:company:f95bc419-f349-4b0d-896d-2572577699d0"],"caused_claim_ids":["alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:7a71310a5f06fcc54110ecee3706ed18f0dacca342c3541f614d391dd6766dcd"],"summary":"David E.I. Pyott seat on ALNYLAM PHARMACEUTICALS, INC., effective 2015-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1j6r3zk15efclq","event_type":"DIRECTOR_APPOINTED","effective_at":"2014-01-01","detected_at":"2026-10-17T04:45:23.017038+00:00","subject_ids":["alpha:person:amy-w-schulman","alpha:company:f95bc419-f349-4b0d-896d-2572577699d0"],"caused_claim_ids":["alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:7a71310a5f06fcc54110ecee3706ed18f0dacca342c3541f614d391dd6766dcd"],"summary":"Amy W. Schulman seat on ALNYLAM PHARMACEUTICALS, INC., effective 2014-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:16cq70ldeac8v","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2014-01-01","detected_at":"2026-10-17T04:45:23.017038+00:00","subject_ids":["alpha:person:amy-w-schulman","alpha:committee:alnylam-pharmaceuticals-inc:nominating-and-governance"],"caused_claim_ids":["alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:committee_record:30"],"evidence_ids":["alpha:projection-evidence:9ba1004d067de3d8e8ee090fc3af01300f3a277f7267ddfe2b5b1800b9366fa8"],"summary":"Amy W. Schulman member of Nominating and Governance, effective 2014-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:sdukie1yk94jm","event_type":"DIRECTOR_APPOINTED","effective_at":"2012-01-01","detected_at":"2026-10-17T04:45:23.017038+00:00","subject_ids":["alpha:person:dennis-a-ausiello","alpha:company:f95bc419-f349-4b0d-896d-2572577699d0"],"caused_claim_ids":["alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:7a71310a5f06fcc54110ecee3706ed18f0dacca342c3541f614d391dd6766dcd"],"summary":"Dennis A. Ausiello seat on ALNYLAM PHARMACEUTICALS, INC., effective 2012-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:7","subject_id":"alpha:company:f95bc419-f349-4b0d-896d-2572577699d0","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:amy-w-schulman","object_label":"Amy W. Schulman","object_source_name_forms":[],"value":"Amy W. Schulman: Director, Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:amy-w-schulman","name":"Amy W. Schulman"},"title":"Director","role_category":"director","committee":"Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2014-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2014-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:23.017038+00:00","sources":[{"id":"alpha:projection-evidence:document:7a71310a5f06fcc54110ecee3706ed18f0dacca342c3541f614d391dd6766dcd","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Alnylam Pharmaceuticals DEF 14A 2026-04-06","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000162828026023923/alny-20260406.htm","source_date":"2026-04-06","retrieved_at":"2026-04-24T15:56:01.293+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-06","effective_from":"2014-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:23.017038+00:00","reviewed_at":"2026-10-17T04:45:23.017038+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:8","subject_id":"alpha:company:f95bc419-f349-4b0d-896d-2572577699d0","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:colleen-f-reitan","object_label":"Colleen F. Reitan","object_source_name_forms":[],"value":"Colleen F. Reitan: Director, Audit","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:colleen-f-reitan","name":"Colleen F. Reitan"},"title":"Director","role_category":"director","committee":"Audit","is_board_chair":false,"is_independent":true,"start_date":"2018-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2018-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:23.017038+00:00","sources":[{"id":"alpha:projection-evidence:document:7a71310a5f06fcc54110ecee3706ed18f0dacca342c3541f614d391dd6766dcd","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Alnylam Pharmaceuticals DEF 14A 2026-04-06","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000162828026023923/alny-20260406.htm","source_date":"2026-04-06","retrieved_at":"2026-04-24T15:56:01.293+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-06","effective_from":"2018-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:23.017038+00:00","reviewed_at":"2026-10-17T04:45:23.017038+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:9","subject_id":"alpha:company:f95bc419-f349-4b0d-896d-2572577699d0","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:david-e-i-pyott","object_label":"David E.I. Pyott","object_source_name_forms":[],"value":"David E.I. Pyott: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:david-e-i-pyott","name":"David E.I. Pyott"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2015-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2015-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:23.017038+00:00","sources":[{"id":"alpha:projection-evidence:document:7a71310a5f06fcc54110ecee3706ed18f0dacca342c3541f614d391dd6766dcd","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Alnylam Pharmaceuticals DEF 14A 2026-04-06","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000162828026023923/alny-20260406.htm","source_date":"2026-04-06","retrieved_at":"2026-04-24T15:56:01.293+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-06","effective_from":"2015-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:23.017038+00:00","reviewed_at":"2026-10-17T04:45:23.017038+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:10","subject_id":"alpha:company:f95bc419-f349-4b0d-896d-2572577699d0","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:dennis-a-ausiello","object_label":"Dennis A. Ausiello","object_source_name_forms":[],"value":"Dennis A. Ausiello: Director, Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:dennis-a-ausiello","name":"Dennis A. Ausiello"},"title":"Director","role_category":"director","committee":"Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2012-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2012-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:23.017038+00:00","sources":[{"id":"alpha:projection-evidence:document:7a71310a5f06fcc54110ecee3706ed18f0dacca342c3541f614d391dd6766dcd","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Alnylam Pharmaceuticals DEF 14A 2026-04-06","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000162828026023923/alny-20260406.htm","source_date":"2026-04-06","retrieved_at":"2026-04-24T15:56:01.293+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-06","effective_from":"2012-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:23.017038+00:00","reviewed_at":"2026-10-17T04:45:23.017038+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:11","subject_id":"alpha:company:f95bc419-f349-4b0d-896d-2572577699d0","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:elliott-sigal","object_label":"Elliott Sigal","object_source_name_forms":[],"value":"Elliott Sigal: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:elliott-sigal","name":"Elliott Sigal"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2022-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2022-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:23.017038+00:00","sources":[{"id":"alpha:projection-evidence:document:7a71310a5f06fcc54110ecee3706ed18f0dacca342c3541f614d391dd6766dcd","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Alnylam Pharmaceuticals DEF 14A 2026-04-06","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000162828026023923/alny-20260406.htm","source_date":"2026-04-06","retrieved_at":"2026-04-24T15:56:01.293+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-06","effective_from":"2022-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:23.017038+00:00","reviewed_at":"2026-10-17T04:45:23.017038+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:12","subject_id":"alpha:company:f95bc419-f349-4b0d-896d-2572577699d0","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:margaret-a-hamburg","object_label":"Marc D. Hamburg","object_source_name_forms":[],"value":"Marc D. Hamburg: Director, Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:margaret-a-hamburg","name":"Marc D. Hamburg"},"title":"Director","role_category":"director","committee":"Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2019-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2019-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:23.017038+00:00","sources":[{"id":"alpha:projection-evidence:document:7a71310a5f06fcc54110ecee3706ed18f0dacca342c3541f614d391dd6766dcd","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Alnylam Pharmaceuticals DEF 14A 2026-04-06","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000162828026023923/alny-20260406.htm","source_date":"2026-04-06","retrieved_at":"2026-04-24T15:56:01.293+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-06","effective_from":"2019-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:23.017038+00:00","reviewed_at":"2026-10-17T04:45:23.017038+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:13","subject_id":"alpha:company:f95bc419-f349-4b0d-896d-2572577699d0","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:olivier-brandicourt","object_label":"Olivier Brandicourt","object_source_name_forms":[],"value":"Olivier Brandicourt: Director, Audit","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:olivier-brandicourt","name":"Olivier Brandicourt"},"title":"Director","role_category":"director","committee":"Audit","is_board_chair":false,"is_independent":true,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:23.017038+00:00","sources":[{"id":"alpha:projection-evidence:document:7a71310a5f06fcc54110ecee3706ed18f0dacca342c3541f614d391dd6766dcd","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Alnylam Pharmaceuticals DEF 14A 2026-04-06","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000162828026023923/alny-20260406.htm","source_date":"2026-04-06","retrieved_at":"2026-04-24T15:56:01.293+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-06","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:23.017038+00:00","reviewed_at":"2026-10-17T04:45:23.017038+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:14","subject_id":"alpha:company:f95bc419-f349-4b0d-896d-2572577699d0","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:peter-n-kellogg","object_label":"Peter N. Kellogg","object_source_name_forms":[],"value":"Peter N. Kellogg: Director, Audit · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:peter-n-kellogg","name":"Peter N. Kellogg"},"title":"Director","role_category":"director","committee":"Audit · Chair","is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:23.017038+00:00","sources":[{"id":"alpha:projection-evidence:document:7a71310a5f06fcc54110ecee3706ed18f0dacca342c3541f614d391dd6766dcd","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Alnylam Pharmaceuticals DEF 14A 2026-04-06","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000162828026023923/alny-20260406.htm","source_date":"2026-04-06","retrieved_at":"2026-04-24T15:56:01.293+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-06","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:23.017038+00:00","reviewed_at":"2026-10-17T04:45:23.017038+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:15","subject_id":"alpha:company:f95bc419-f349-4b0d-896d-2572577699d0","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:stuart-a-arbuckle","object_label":"Stuart A. Arbuckle","object_source_name_forms":[],"value":"Stuart A. Arbuckle: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:stuart-a-arbuckle","name":"Stuart A. Arbuckle"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2026-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:23.017038+00:00","sources":[{"id":"alpha:projection-evidence:document:7a71310a5f06fcc54110ecee3706ed18f0dacca342c3541f614d391dd6766dcd","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Alnylam Pharmaceuticals DEF 14A 2026-04-06","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000162828026023923/alny-20260406.htm","source_date":"2026-04-06","retrieved_at":"2026-04-24T15:56:01.293+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-06","effective_from":"2026-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:23.017038+00:00","reviewed_at":"2026-10-17T04:45:23.017038+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:16","subject_id":"alpha:company:f95bc419-f349-4b0d-896d-2572577699d0","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:yvonne-l-greenstreet-2","object_label":"Yvonne L. Greenstreet","object_source_name_forms":[],"value":"Yvonne L. Greenstreet: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:yvonne-l-greenstreet-2","name":"Yvonne L. Greenstreet"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:23.017038+00:00","sources":[{"id":"alpha:projection-evidence:document:7a71310a5f06fcc54110ecee3706ed18f0dacca342c3541f614d391dd6766dcd","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Alnylam Pharmaceuticals DEF 14A 2026-04-06","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000162828026023923/alny-20260406.htm","source_date":"2026-04-06","retrieved_at":"2026-04-24T15:56:01.293+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-06","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:23.017038+00:00","reviewed_at":"2026-10-17T04:45:23.017038+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:committee_record:26","subject_id":"alpha:company:f95bc419-f349-4b0d-896d-2572577699d0","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Audit: Chair Peter N. Kellogg; Members Peter N. Kellogg (Chair); Colleen F. Reitan; Olivier Brandicourt","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Audit","canonical_type":"audit","chair":"Peter N. Kellogg","members":[{"display_name":"Peter N. Kellogg","person_slug":"peter-n-kellogg","is_chair":true},{"display_name":"Colleen F. Reitan","person_slug":"colleen-f-reitan","is_chair":false},{"display_name":"Olivier Brandicourt","person_slug":"olivier-brandicourt","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:45:23.017038+00:00","sources":[{"id":"alpha:projection-evidence:9ba1004d067de3d8e8ee090fc3af01300f3a277f7267ddfe2b5b1800b9366fa8","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1178670/000162828026023923/alny-20260406.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:45:23.017038+00:00","reviewed_at":"2026-10-17T04:45:23.017038+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:committee_record:30","subject_id":"alpha:company:f95bc419-f349-4b0d-896d-2572577699d0","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Nominating and Governance: Chair not stated; Members Amy W. Schulman; Dennis A. Ausiello; Marc D. Hamburg","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Nominating and Governance","canonical_type":"nominating_governance","chair":null,"members":[{"display_name":"Amy W. Schulman","person_slug":"amy-w-schulman","is_chair":false},{"display_name":"Dennis A. Ausiello","person_slug":"dennis-a-ausiello","is_chair":false},{"display_name":"Marc D. Hamburg","person_slug":"margaret-a-hamburg","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:45:23.017038+00:00","sources":[{"id":"alpha:projection-evidence:9ba1004d067de3d8e8ee090fc3af01300f3a277f7267ddfe2b5b1800b9366fa8","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1178670/000162828026023923/alny-20260406.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:45:23.017038+00:00","reviewed_at":"2026-10-17T04:45:23.017038+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:7a71310a5f06fcc54110ecee3706ed18f0dacca342c3541f614d391dd6766dcd","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Alnylam Pharmaceuticals DEF 14A 2026-04-06","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000162828026023923/alny-20260406.htm","source_date":"2026-04-06","retrieved_at":"2026-04-24T15:56:01.293+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:9ba1004d067de3d8e8ee090fc3af01300f3a277f7267ddfe2b5b1800b9366fa8","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1178670/000162828026023923/alny-20260406.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.8,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.695,"cross_source_agreement":0.75,"temporal_completeness":0.423},"diagnostics":{"published_claims":33,"factual_claims":33,"claims_with_linked_evidence":33,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":26,"temporal_claims_with_valid_from":11,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-17T04:45:23.017038+00:00","observed_at":"2026-10-17T04:45:23.017038+00:00","reviewed_at":"2026-10-17T04:45:23.017038+00:00","verified_at":"2026-10-17T04:45:23.017038+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":33,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/alnylam-pharmaceuticals-inc/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/alnylam-pharmaceuticals-inc?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}